# FDA Inspection 832504 - American National Red Cross - May 22, 2013

Source: https://www.keypedia.com/records/fda_inspections/american-national-red-cross/9ada728a-6c32-4746-b85f-c3d7becc34b3
Source feed: FDA_Inspections

> FDA Inspection 832504 for American National Red Cross on May 22, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 832504
- Company Name: American National Red Cross
- Inspection Date: 2013-05-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1097503 - 2019-06-26](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/3f303b18-1d8f-4252-ab27-d6f862b70dec)
- [FDA Inspection 1018315 - 2017-06-08](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/b3d667b2-4ca4-49a2-acc8-41c8f9d11ab8)
- [FDA Inspection 906509 - 2014-12-05](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/32190397-9a57-416a-ab0a-0c60b2a76855)
- [FDA Inspection 744053 - 2011-09-01](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/7197be12-513c-45b1-9e8e-c5ad196f0093)
- [FDA Inspection 584499 - 2009-05-20](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/6844a49b-e322-4598-8621-a00adc1b3cad)

Company: https://www.keypedia.com/companies/american-national-red-cross/ee841b85-ecd6-42d5-99d4-efaef9a6cbc3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d